Current Report Filing (8-k)
July 12 2022 - 4:28PM
Edgar (US Regulatory)
0001376793
false
0001376793
2022-07-07
2022-07-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 7, 2022
Cavitation Technologies, Inc.
(Exact name of registrant as specified in its charter)
Nevada |
02-9901 |
20-4907818 |
(State or Other Jurisdiction |
(Commission |
(I.R.S. Employer |
of Incorporation) |
File Number) |
Identification No.) |
10019 Canoga Ave.
Chatsworth, California 91311
(Address of Principal Executive Offices) (Zip Code)
(818) 718-0905
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
|
|
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
SECTION 5 — CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On July 5, 2022, Igor Gorodnitsky, the President of Cavitation Technologies, Inc. (the “Company”), voluntarily resigned from such position, effective July 7, 2022, for personal reasons relating to his health. Mr. Gorodnitsky’s resignation as President of the Company is not the result of any disagreement with the Company, including any matter relating to the Company’s operations, policies, or procedures.
Additionally, Mr. Gorodnitsky voluntarily resigned from the Company’s Board of Directors, also effective July 7, 2022. Mr Gorodnitsky’s resignation as a Director of the Company is not the result of any disagreement with the Company, including any matter relating to the Company’s operations, policies, or procedures.
A press release will be issued by the
Company following the filing of this form.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
Cavitation Technologies, Inc. |
|
|
|
By |
/s/ Naum Voloshin |
|
|
Name: Naum Voloshin
Title: CFO |
Date: July 12, 2022
Cavitation Technologies (QB) (USOTC:CVAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cavitation Technologies (QB) (USOTC:CVAT)
Historical Stock Chart
From Oct 2023 to Oct 2024